Ranibizumab Population Pharmacokinetics and Free VEGF Pharmacodynamics in Preterm Infants With Retinopathy of Prematurity in the RAINBOW Trial
Author(s) -
Matthew Fidler,
Brian W. Fleck,
Andreas Stahl,
Neil Marlow,
James E. Chastain,
Jun Li,
Domenico Lepore,
James D. Reynolds,
Michael F. Chiang,
Alistair R. Fielder
Publication year - 2020
Publication title -
translational vision science and technology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.508
H-Index - 21
ISSN - 2164-2591
DOI - 10.1167/tvst.9.8.43
Subject(s) - retinopathy of prematurity , population pharmacokinetics , medicine , pharmacodynamics , ranibizumab , pharmacokinetics , vegf receptors , population , ophthalmology , pharmacology , pediatrics , bevacizumab , gestational age , pregnancy , biology , genetics , chemotherapy , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom